ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 161 filers reported holding ANIKA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $473,771 | -12.8% | 18,236 | -3.6% | 0.00% | 0.0% |
| Q1 2023 | $543,440 | -6.0% | 18,922 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $578,147 | +5.9% | 19,532 | -14.8% | 0.00% | 0.0% |
| Q3 2022 | $546,000 | -1.4% | 22,922 | -7.6% | 0.00% | 0.0% |
| Q2 2022 | $554,000 | +45.4% | 24,802 | +63.3% | 0.00% | 0.0% |
| Q1 2022 | $381,000 | -30.7% | 15,192 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $550,000 | -16.3% | 15,352 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $657,000 | -2.7% | 15,447 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $675,000 | -1.2% | 15,587 | -6.9% | 0.00% | 0.0% |
| Q1 2021 | $683,000 | -25.4% | 16,744 | -17.2% | 0.00% | -50.0% |
| Q4 2020 | $915,000 | +3.5% | 20,219 | -19.1% | 0.00% | 0.0% |
| Q3 2020 | $884,000 | -82.0% | 24,981 | -80.8% | 0.00% | -77.8% |
| Q2 2020 | $4,913,000 | +20.9% | 130,214 | -7.4% | 0.01% | 0.0% |
| Q1 2020 | $4,064,000 | -61.4% | 140,596 | -30.7% | 0.01% | -43.8% |
| Q4 2019 | $10,524,000 | -3.2% | 202,971 | +2.4% | 0.02% | -5.9% |
| Q3 2019 | $10,875,000 | +145.7% | 198,120 | +81.8% | 0.02% | +142.9% |
| Q2 2019 | $4,427,000 | +124.9% | 108,989 | +67.5% | 0.01% | +133.3% |
| Q1 2019 | $1,968,000 | +147.5% | 65,073 | +175.1% | 0.00% | +200.0% |
| Q4 2018 | $795,000 | -22.6% | 23,655 | -2.8% | 0.00% | -50.0% |
| Q3 2018 | $1,027,000 | +27.1% | 24,340 | -3.6% | 0.00% | +100.0% |
| Q2 2018 | $808,000 | -35.4% | 25,250 | +0.4% | 0.00% | -50.0% |
| Q1 2018 | $1,250,000 | -4.7% | 25,150 | +3.4% | 0.00% | 0.0% |
| Q4 2017 | $1,312,000 | -8.9% | 24,330 | -2.0% | 0.00% | 0.0% |
| Q3 2017 | $1,440,000 | +17.2% | 24,830 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $1,229,000 | +10.9% | 24,900 | -2.4% | 0.00% | 0.0% |
| Q1 2017 | $1,108,000 | -11.9% | 25,510 | -0.7% | 0.00% | 0.0% |
| Q4 2016 | $1,258,000 | -9.1% | 25,690 | -11.2% | 0.00% | 0.0% |
| Q3 2016 | $1,384,000 | -36.7% | 28,920 | -29.0% | 0.00% | -50.0% |
| Q2 2016 | $2,186,000 | +36.2% | 40,740 | +13.5% | 0.00% | +33.3% |
| Q1 2016 | $1,605,000 | +23.0% | 35,880 | +4.9% | 0.00% | +50.0% |
| Q4 2015 | $1,305,000 | +20.9% | 34,200 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,079,000 | -2.8% | 33,900 | +0.9% | 0.00% | 0.0% |
| Q2 2015 | $1,110,000 | -37.3% | 33,600 | -21.9% | 0.00% | -33.3% |
| Q1 2015 | $1,770,000 | +3.7% | 43,000 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $1,707,000 | +19.4% | 41,900 | +7.4% | 0.00% | 0.0% |
| Q3 2014 | $1,430,000 | -80.7% | 39,000 | -75.6% | 0.00% | -76.9% |
| Q2 2014 | $7,417,000 | +89.5% | 160,100 | +68.2% | 0.01% | +85.7% |
| Q1 2014 | $3,913,000 | +36.7% | 95,200 | +26.9% | 0.01% | +16.7% |
| Q4 2013 | $2,862,000 | +445.1% | 75,000 | +242.5% | 0.01% | +500.0% |
| Q3 2013 | $525,000 | +196.6% | 21,900 | +110.6% | 0.00% | – |
| Q2 2013 | $177,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
| Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
| DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
| Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
| Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
| Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
| Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
| BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
| Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
| Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |